Document Type : Research Paper
Authors
Abstract
The purpose of this study was the preconditioning effect of aerobic exercise with d3 vitamin consumption on VEGF levels in the 6-ohda lesioned Parkinson's disease rat model. 48 male rats with the age of 7 weeks and weight 250-300 gr, randomly divided to 6 groups: healthy control, Parkinson’s control, sham, exercise -Parkinson, vitamin- Parkinson, exercise+ vitamin - Parkinson. The exercise groups, exercised for 4 weeks, 5 days per week for 30 minutes on treadmill at a speed of 15 meters per minute and with a slope of zero. The vitamin groups, received vitamin d3 for 4 weeks, 2 days per week and with a dose of 1 mg/kg of body weight. After 4 weeks of exercise and d3 vitamin consumption, was created an experimental model of Parkinson's disease using stereotactic surgery and injections of 6-hydroxy dopamine in the striatum. 3 weeks after this, Apo morphine rotational test was conducted in order to verify the parkinsonian rats and then were measured VGEF levels in the striatum by Elisa method after destruction and extraction of the striatum of the rats’ brain. The results show that, 4 weeks’ treadmill aerobic exercise with d3 vitamin consumption, before 6-hydroxy-dopamine induction, could significantly increase VGEF levels in the striatum (P≤0.005). In general, the results of this study showed that preconditioning with aerobic exercise with d3 vitamin can be caused increasing of dopaminergic neurons protection against degradation resulting of 6-hydroxy dopamine by increasing the levels of VGEF and play a protective role in Parkinson's disease.
Keywords
Main Subjects
- Rivka R, Isidro F. Brain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson’s disease. FEBS Journal. 2012; 279(7): 1167–76.
- Lewis S J, Barker R A. Understanding the dopaminergic deficits in Parkinson’s disease: Insights into disease heterogeneity. Journal of Clinical Neuroscience. 2009; 16(5): 620-5.
- Huang Z, Fuente-Fernández R D L, Stoessl A J. Etiology of Parkinson's disease. The Canadian Journal of Neurological Sciences. 2003; 30(4): 10-8.
- Anstrom K K, Schallert T, Woodlee M T, Shattuck A, Roberts D. Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease. Behavioural Brain Research. 2007; 179(2): 183-91.
- PengSun Z, Gong L, Huang SH, Geng Z, Cheng L, Chen ZY. Intracellular trafficking and secretion of cerebral dopamine neurotrophic factor in neurosecretory cells. Journal of Neurochimistry. 2011; 117(1): 121-32.
- Jes P, Korah P, Kuruvilla J M, Peeyush K, Paulose C S. Dopamine D 1 and D 2 receptor subtypes functional regulation in cerebral cortex of unilateral rotenone elesioned Parkinson’ s rat model: Effect of serotonin, dopamine and norepinephrine. Parkinsonism and Related Disorders. 2011; 17(4): 255-9.
- Zigmond M J, Smeyne R J. Exercise: Is it a neuroprotective and if so, how does it work? Parkinsonism & Related Disorders. 2014; 20(1): 123-7.
- Radak Z, Kumagai Sh, Taylor A W, Naito H, Goto S. Effects of exercise on brain function: Role of freeradicals. Appl Physiol Nutr Metab. 2007; 32(5): 942-6.
- Wu S Y, W. T. Running exercise protects the substantia dopaminergic neurons against inflammation via the activation of BDNF signaling pathway. Brain, Behavior and Immunity 2011; 25(1): 135-46.
10. Choe M, Koo B S, An G J, Jeon S. Effects of treadmill exercise on the recovery of dopaminergic neuron loss and muscle atrophy in the 6-OHDA lesioned Parkinson's disease rat model. The Korean Journal of Physiology & Pharmacology. 2012; 16(5): 305-12.
11. Yasuhara T, Hara K, Maki M, Matsukawa N, Fujino H, Date I, et al. Lack of exercise, via hindlimb suspension, impedes endogenous neurogenesis. Neuroscience. 2007; 149(1): 182–91.
12. Yasuhara T, Shingo T, Date I. The potential role of vascular endothelial growth factor in the central nervous system. Rev Neurosci. 2004; 15(4): 293-307.
13. Martinez-Campos C, Lara-Padilla E, Bobadilla-Lugo R A, Kross R D, Villanueva C. Effects of exercise on oxidative stress in rats induced by ozone. Scientific World Journal. 2012; 13(5):1-5.
14. Cadet J, Last R, Osticv K, Rezedborski P, Lewis V J. Long term behavioral and biochemical effect of 6-OHDA injection in. Rat Caudate Putamen Bain Res Ball. 1991; 26(2): 707-13.
15. Al-Jarrah M. Exercise training and rehabilitation of brain in Parkinson’s disease. Clinical Medicine Research. 2013; 2(2): 11-7.
16. Chitsaz A, Maracy M, Basiri K, Izadi Boroujeni M, Tanhaei A P, Rahimi M, et al. 25-Hydroxyvitamin D and severity of Parkinson’s disease. International Journal of endocrinology. 2013; 68(2): 1-4
17. Kalueff A V, Minasyan A, Tuohimaa P. Anticonvulsant effects of 1, 25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Research Bulletin. 2005; 67(1): 156-60.
18. Eyles D W, Burne T H, McGrath J J. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology. 2013; 34(1): 47-64.
19. Sanchez B, Relova J L, Gallego R, Ben‐Batalla I, Perez‐Fernandez R. 1, 25‐ Dihydroxyvitamin D3 administration to 6‐hydroxydopamine‐lesioned rats increases glial cell line‐derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. Journal of Neuroscience Research. 2009; 87(3): 723-32.
20. Tao W, Yan-Yong L, Xin W, Nan Y, Hai-Bo Z, Ping-Ping Z. Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling. Acta Pharmacologica Sinica. 2010; 31(7): 765–74.
21. Mabandla M V, Russell V A. Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats. Behavioural Brain Research. 2010; 211(1): 16-22.
22. Landers M R, Kinney J W, Breukelen F V. Forced exercise before or after induction of 6-OHDA-mediated nigrostriatal insult does not mitigate behavioral asymmetry in a hemiparkinsonian rat model. Brain Research. 2014; 15(43): 263-70.
23. Riaz S, Malcangio M, Miller M, Tomlinson D R. A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia. 1999; 42(11): 1308-13.
24. Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T, et al. Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Research. 2010; 13(10): 200-7.
25. Al-Jarrah M, Jamous M, Al-Zailaey K, O.Bweir S. Endurance exercise training promotes angiogenesis in the brain of chronic/progressive mouse model of Parkinson's disease. Neuro Rehabilitation. 2010; 26(4): 369-73.
26. فلاحمحمدی ضیا، حاجیزاده مقدم اکبر، آقاسی محمد، اسماعیلی امیرحسین. اثر حفاظتی تمرین اختیاری همراه با عصارۀ هیدروالکلی گل گیاه ازگیل ژاپنی بر سطح دوپامین و تیروزین هیدروکسیلاز جسم مخطط موشهای پارکینسونی. نشریۀ علوم پزشکی سمنان. 1391؛ 15( 1): 8ـ31.
27. فلاحمحمدی ضیا، محمدی راضیه، اصلانی جلیل. اثر پیشدرمان عصارۀ گل گیاه ازگیل ژاپنی بر سطوح BDNF، SOD و MDA در هیپوکامپ موشهای در معرض 6 هیدروکسی دوپامین بهدنبال 12 هفته تمرین اختیاری. نشریۀ دانشکدۀ پزشکی اصفهان. 1393؛ 32 (274): 30ـ120.
28. Murray D K, Sacheli M A, Eng J J, Stoessl A J. The effects of exercise on cognition in Parkinson’s disease: A systematic review. Translational Neurodegeneration. 2014; 3(5): 1-13.
29. Villar-Cheda B, Sousa-Ribeiro D, Rodriguez-Pallares J, Rodriguez-Perez A I, Guerra M J, Labandeira-Garcia J L. Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease. Journal of Cerebral Blood Flow & Metabolism. 2008; 29(2): 230-4.
30. طاهری چادرنشین حسین، نورشاهی مریم، رنجبر کمال. مقایسۀ پروتئازهای آنژیوژنیکی مردان فعال و غیرفعال بهدنبال فعالیت ورزشی زیربیشینه. فیزیولوژی ورزشی. تابستان 1390؛ 3(10): 158ـ143.
31. Wang J Y, Wu J N, Cheng T L, Hoffer B J, Chen H H, Borlongan C V, et al. Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Research. 2001; 904(1): 67-75.
32. Dutra M F, Jaeger M, Ilha J, Kalil-Gaspar P I, Marcuzzo S, Achaval M. Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDAinduced rat model of Parkinson's disease. Neurol Sci. 2012; 33(5): 1137-44.
33. Yue X, Hariri D J, Caballero B, Zhang S, Bartlett M J, Kaut O, et al. Comparative study of the neurotrophic effects elicited by vegf-B and gdnf in preclinical in vivo models of Parkinson’s disease. Neuroscience. 2014; 258(1): 385–400.
)